These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8533458)

  • 1. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein.
    Ray RB; Lagging LM; Meyer K; Steele R; Ray R
    Virus Res; 1995 Aug; 37(3):209-20. PubMed ID: 8533458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Identification and evaluation promoter sequence and the transcription activation of Hcbp6 interaction with core protein of hepatitis C virus].
    Wang L; Cheng J; Li K; Hong Y
    Zhonghua Gan Zang Bing Za Zhi; 2006 Feb; 14(2):81-5. PubMed ID: 16494772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus surface (S) transactivator with DNA-binding properties.
    Alka S; Hemlata D; Vaishali C; Shahid J; Kumar PS
    J Med Virol; 2000 May; 61(1):1-10. PubMed ID: 10745225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the transcriptional transactivation function of simian virus 40 large T antigen.
    Zhu JY; Rice PW; Chamberlain M; Cole CN
    J Virol; 1991 Jun; 65(6):2778-90. PubMed ID: 1851853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of Rous sarcoma virus long terminal repeat promoter activity by a HeLa cell basic protein.
    Yeh CH; Shatkin AJ
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11002-6. PubMed ID: 7971997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of viral and cellular promoters by human wild-type p53.
    Subler MA; Martin DW; Deb S
    J Virol; 1992 Aug; 66(8):4757-62. PubMed ID: 1352831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53-Dependent and -independent transactivation by the E6 protein of human papillomavirus type 16.
    Akutsu N; Shirasawa H; Asano T; Isono K; Simizu B
    J Gen Virol; 1996 Mar; 77 ( Pt 3)():459-63. PubMed ID: 8601782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.
    Jeeninga RE; Hoogenkamp M; Armand-Ugon M; de Baar M; Verhoef K; Berkhout B
    J Virol; 2000 Apr; 74(8):3740-51. PubMed ID: 10729149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trans-suppression of gene expression by hepatitis C viral core protein.
    Kim DW; Suzuki R; Harada T; Saito I; Miyamura T
    Jpn J Med Sci Biol; 1994 Aug; 47(4):211-20. PubMed ID: 7715094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activating protein-1 cooperates with phorbol ester activation signals to increase HIV-1 expression.
    Roebuck KA; Gu DS; Kagnoff MF
    AIDS; 1996 Jul; 10(8):819-26. PubMed ID: 8828738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene.
    Chang J; Yang SH; Cho YG; Hwang SB; Hahn YS; Sung YC
    J Virol; 1998 Apr; 72(4):3060-5. PubMed ID: 9525629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Rous sarcoma virus long terminal repeat promoter is regulated by TFII-I.
    Mobley CM; Sealy L
    J Virol; 2000 Jul; 74(14):6511-9. PubMed ID: 10864664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The serum unresponsive Rous sarcoma virus promoter sustains a high serum response factor-dependent transcription in vitro.
    Trouche D; Grigoriev M; Robin P; Harel-Bellan A
    Biochem Biophys Res Commun; 1993 Oct; 196(2):611-8. PubMed ID: 8240335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transfer of active oncogenes and promoters into the mouse cell genome].
    Tatosian AG; Topol' LZ; Ambartsumian NS
    Mol Biol (Mosk); 1986; 20(5):1226-35. PubMed ID: 3022122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human herpesvirus 6A ts suppresses both transformation by H-ras and transcription by the H-ras and human immunodeficiency virus type 1 promoters.
    Araujo JC; Doniger J; Kashanchi F; Hermonat PL; Thompson J; Rosenthal LJ
    J Virol; 1995 Aug; 69(8):4933-40. PubMed ID: 7609062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus core protein inhibits human immunodeficiency virus type 1 replication.
    Srinivas RV; Ray RB; Meyer K; Ray R
    Virus Res; 1996 Dec; 45(2):87-92. PubMed ID: 8896243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transrepression of RNA polymerase II promoters by the simian virus 40 small t antigen.
    Wang WB; Bikel I; Marsilio E; Newsome D; Livingston DM
    J Virol; 1994 Oct; 68(10):6180-7. PubMed ID: 8083958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies.
    Mukhtar M; Duan L; Bagasra O; Pomerantz RJ
    Gene Ther; 1996 Aug; 3(8):725-30. PubMed ID: 8854098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of promoters for trans activation by a carboxy-terminal domain of the NS-1 protein of the parvovirus minute virus of mice.
    Legendre D; Rommelaere J
    J Virol; 1994 Dec; 68(12):7974-85. PubMed ID: 7966588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of SV40 early 5' distal sequences in directing heterologous gene expression.
    Coleman TA; Hou YT; Kopchick JJ
    Gene; 1991 Oct; 106(2):243-8. PubMed ID: 1657724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.